Mike Strazzella, Practice Group Leader of Buchanan's Federal Government Relations practice and head of the firm's Washington D.C. office, comments on President Trump's and Pfizer's recent interactions that led to a temporary decrease in drug pricing in Stat News' article "What Pfizer, Trump and Consumers Got Out of a Surprising Deal - And What They Didn't."